LSTM Home > LSTM Research > LSTM Online Archive

Foley catheter vs. oral misoprostol to induce labour among hypertensive women in India: A cost-consequence analysis alongside a clinical trial.


Downloads per month over past year

Leigh, Simon, Granby, Paul, Haycox, Alan, Mundle, Shuchita, Bracken, Hillary, Khedikar, Vaishali, Mulik, Jayashree, Faragher, Brian, Easterling, Thomas, Turner, Mark A, Alfirevic, Zarko, Winikoff, Beverly and Weeks, Andrew D (2018) 'Foley catheter vs. oral misoprostol to induce labour among hypertensive women in India: A cost-consequence analysis alongside a clinical trial.'. BJOG: An International Journal of Obstetrics & Gynaecology.

BJOG__foley catheter.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (175kB) | Preview


To determine the effectiveness and economic impact of two methods for induction of labour in hypertensive women, in low-resource settings.
Cost-consequence analysis of a previously reported multi-centre, parallel, open-label randomized trial.
602 women with a live fetus, aged>18 years requiring delivery for pre-eclampsia or hypertension, in two public hospitals in Nagpur, India.
We performed a formal economic evaluation alongside the INFORM clinical trial. Women were randomised to receive transcervical Foley catheterisation or oral misoprostol 25mcg. Healthcare expenditure was calculated using a provider-side micro-costing approach.
Rates of vaginal delivery within 24hours of induction, healthcare-expenditure per completed treatment episode.
Induction with oral misoprostol resulted in lower healthcare expenditure, mean difference (-)$20.6USD [95%CI ((-)$12.73USD-(-)26.74USD)], and improved achievement of vaginal delivery within 24hours of induction, mean difference 10% [95%CI (-2%-17.9%), p=0.016)]. Oxytocin administration time was reduced by 135.3minutes [95%CI (84.4-186.2mins), p<0.01), and Caesarean sections by 9.1% [95%CI (1.1%-17%), p=0.025)] for those receiving oral misoprostol. Following probabilistic sensitivity analysis, oral misoprostol was cost saving in 63% of 5,000 bootstrap replications and achieved superior rates of delivery within 24 hours of induction, vaginal delivery, and vaginal delivery within 24 hours of induction in 90.7%, 98.7% and 99.4% of bootstrap simulations. Based on univariate threshold analysis, the unit price of oral misoprostol 25mcg could feasibly increase 31-fold from $0.24 to $7.50 per 25mcg tablet and remain cost saving.
Compared to Foley catheterisation for the induction of high-risk hypertensive women, oral misoprostol improves rates of vaginal delivery within 24h of induction and may also reduce costs. Additional research performed in other low-resource settings is required to determine their relative cost-effectiveness. This article is protected by copyright. All rights reserved.

Item Type: Article
Subjects: W General Medicine. Health Professions > W 74 Medical economics. Health care costs
QV Pharmacology > Cardiovascular Agents. Renal Agents > QV 150 Cardiovascular agents
WA Public Health > WA 30 Socioeconomic factors in public health (General)
WA Public Health > Health Problems of Special Population Groups > WA 310 Maternal welfare
WG Cardiovascular System > WG 100 General works
WQ Obstetrics > Labor > WQ 300 General works
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):
Depositing User: Stacy Murtagh
Date Deposited: 25 May 2018 14:44
Last Modified: 28 Jun 2018 08:28


View details

Actions (login required)

Edit Item Edit Item